Open AccessRenal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: A pooled analysis of 26 clinical trials
Author(s) -
Samir K. Gupta,
Frank A. Post,
José Ramón Arribas,
Joseph J. Eron,
David A. Wohl,
Amanda Clarke,
Paul E. Sax,
HansJürgen Stellbrink,
Stefan Eßer,
Anton Pozniak,
Daniel Podzamczer,
Laura Waters,
Chloe Orkin,
Jürgen K. Rockstroh,
Tatiana Mudrikova,
Eugènia Negredo,
Richard Elion,
Susan Guo,
Lijie Zhong,
Christoph Carter,
Hal Martin,
Diana M. Brainard,
Devi SenGupta,
Moupali Das
Publication year - 2019
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/6n8m-c258
Subject(s) - tenofovir alafenamide , tenofovir , medicine , clinical trial , elvitegravir , rilpivirine , pharmacology , virology , human immunodeficiency virus (hiv) , antiretroviral therapy , viral load